Report Buyer, the online destination for business intelligence for major industry sectors, has now added a new report on the market for tuberculosis testing and therapeutics products. Global Tuberculosis Strategies forecasts the total market potential for these products exceeds $8 billion based on currently reported TB status and pricing structures.
Tuberculosis is again presenting a major public health crisis even though it was nearly extinct at the end of the last century. More than 1.6 billion people are infected and global hotspots continue to be burdened with insufficient screening, diagnosis, and treatment.
This disease requires a cure for the individual and minimisation of its transmission to others. This requires advanced screenings and treatments being made available to hard hit regions. Because of the contagiousness of this disease, there are huge payoffs for investment in diagnostics and therapeutics, which have not yet been tapped.
Lack of proper diagnosis is a major barrier to tuberculosis treatment, and the report details current screening techniques and the potential market for advanced diagnostic products. Skin testing remains the most common form of testing and though the Mantoux test dominates, others are
being developed that will impact the market. Sputum smears and cultures, considered better options for diagnosis, lag behind skin testing as they pose difficulties in field use.
The report illustrates three primary focal points for the development of a global strategy for combating tuberculosis. This includes potential market, epidemiology (tuberculosis patient trends) and technology. It also reviews how diagnostic and pharmaceutical companies can incorporate these focal points into their own TB eradication plan.
The study contains an extensive tuberculosis etiology, epidemiologic statistics, including 30 tables of incidence, prevalence, and mortality statistics by country, region, and type of tuberculosis, and a comprehensive glossary of terms. It also includes theoretical market sizes for screening/diagnosis as well as treatment by region and by type of TB (MDR and non-MDR) and a comprehensive review of products for the treatment of TB.
Report Buyer product ID: KAL00024
